Literature DB >> 17125854

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

Masoud Vedadi1, Jocelyne Lew, Jennifer Artz, Mehrnaz Amani, Yong Zhao, Aiping Dong, Gregory A Wasney, Mian Gao, Tanya Hills, Stephen Brokx, Wei Qiu, Sujata Sharma, Angelina Diassiti, Zahoor Alam, Michelle Melone, Anne Mulichak, Amy Wernimont, James Bray, Peter Loppnau, Olga Plotnikova, Kate Newberry, Emayavaram Sundararajan, Simon Houston, John Walker, Wolfram Tempel, Alexey Bochkarev, Ivona Kozieradzki, Aled Edwards, Cheryl Arrowsmith, David Roos, Kevin Kain, Raymond Hui.   

Abstract

Parasites from the protozoan phylum Apicomplexa are responsible for diseases, such as malaria, toxoplasmosis and cryptosporidiosis, all of which have significantly higher rates of mortality and morbidity in economically underdeveloped regions of the world. Advances in vaccine development and drug discovery are urgently needed to control these diseases and can be facilitated by production of purified recombinant proteins from Apicomplexan genomes and determination of their 3D structures. To date, both heterologous expression and crystallization of Apicomplexan proteins have seen only limited success. In an effort to explore the effectiveness of producing and crystallizing proteins on a genome-scale using a standardized methodology, over 400 distinct Plasmodium falciparum target genes were chosen representing different cellular classes, along with select orthologues from four other Plasmodium species as well as Cryptosporidium parvum and Toxoplasma gondii. From a total of 1008 genes from the seven genomes, 304 (30.2%) produced purified soluble proteins and 97 (9.6%) crystallized, culminating in 36 crystal structures. These results demonstrate that, contrary to previous findings, a standardized platform using Escherichia coli can be effective for genome-scale production and crystallography of Apicomplexan proteins. Predictably, orthologous proteins from different Apicomplexan genomes behaved differently in expression, purification and crystallization, although the overall success rates of Plasmodium orthologues do not differ significantly. Their differences were effectively exploited to elevate the overall productivity to levels comparable to the most successful ongoing structural genomics projects: 229 of the 468 target genes produced purified soluble protein from one or more organisms, with 80 and 32 of the purified targets, respectively, leading to crystals and ultimately structures from one or more orthologues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125854     DOI: 10.1016/j.molbiopara.2006.10.011

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  104 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Crystallization and preliminary X-ray diffraction of malate dehydrogenase from Plasmodium falciparum.

Authors:  Carsten Wrenger; Ingrid B Müller; Sabine Butzloff; Rositsa Jordanova; Sergey Lunev; Matthew R Groves
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

3.  Protein subunit interfaces: A statistical analysis of hot spots in Sm proteins.

Authors:  Srđan D Stojanović; Božidarka L Zarić; Snežana D Zarić
Journal:  J Mol Model       Date:  2010-07-23       Impact factor: 1.810

4.  Purification, crystallization and preliminary X-ray diffraction of the G3BP1 NTF2-like domain.

Authors:  Tina Vognsen; Ingvar Rúnar Möller; Ole Kristensen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-12-21

Review 5.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

Review 6.  Global phenotypic screening for antimalarials.

Authors:  W Armand Guiguemde; Anang A Shelat; Jose F Garcia-Bustos; Thierry T Diagana; Francisco-Javier Gamo; R Kiplin Guy
Journal:  Chem Biol       Date:  2012-01-27

7.  Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.

Authors:  Hirokazu Sakamoto; Satoru Takeo; Eizo Takashima; Kazutoyo Miura; Bernard N Kanoi; Takamasa Kaneko; Eun-Taek Han; Mayumi Tachibana; Kazuhiro Matsuoka; Jetsumon Sattabongkot; Rachanee Udomsangpetch; Tomoko Ishino; Takafumi Tsuboi
Journal:  Parasitol Int       Date:  2017-12-05       Impact factor: 2.230

8.  Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR.

Authors:  Gustavo P Riboldi; Rachael Zigweid; Peter J Myler; Stephen J Mayclin; Rafael M Couñago; Bart L Staker
Journal:  RSC Med Chem       Date:  2020-10-22

9.  The ClpP N-terminus coordinates substrate access with protease active site reactivity.

Authors:  Laura D Jennings; Jen Bohon; Mark R Chance; Stuart Licht
Journal:  Biochemistry       Date:  2008-09-25       Impact factor: 3.162

10.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.